The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest injectable drug delivery devices market share.

The global injectable drug delivery devices market is expected to grow from $39.93 billion in 2022 to $43.54 billion in 2023 at a compound annual growth rate (CAGR) of 9.0%. The global injectable drug delivery devices market size is expected to grow from $58.1 billion in 2027 at a CAGR of 7.5%.

Major Driver In The Injectable Drug Delivery Devices Market ­– Increase In The Preference For Self-Injection Devices
Self-injection devices are medical equipment that patients can use at home to administer medication to themselves. Needle-free, auto, pen, and wearable injectors are examples of self-injection technologies. These self-injectables were designed to be the most versatile device with high accuracy drug delivery and ease of use. Furthermore, with advancements in self-injectable devices, adoption of these items has grown in recent years. Becton, Dickinson, and Company’s BD Physioject is a disposable auto-injector that is clinically proven, reliable, and cost-effective for self-injection of drugs by patients suffering from chronic diseases such as rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis. Abbvie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc., and other firms are also active in the self-injections sector. The benefits of self-injectable injections, as well as enhanced self-administration awareness, have increased demand for self-injectable devices, which will drive the injectable drug delivery devices market over the projection period.

View More On The Injectable Drug Delivery Devices Market Report 2023 – https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Key Injectable Drug Delivery Devices Market Segments
1) By Type: Conventional Injectable, Pre-filled Syringes, Auto-injectors, Pen-injectors
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End User: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users

Recent Injectable Drug Delivery Devices Market Trend – Focusing On The Manufacturing Of Auto-Injectors
Auto-injectors are fully automated, highly customised, and reusable injectors that a patient can use to provide hundreds of injections. Patients can vary the rate at which the dose is delivered to help reduce pain or discomfort during injection. These gadgets allow you to change the pace and depth of the automatic injection. LISA, a reusable auto-injector developed by Unilife Corporation, for example, includes a slew of highly adjustable capabilities such as Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection medication warming for target therapy. Due to several technological advances and new product launches to increase the convenience and ease of administration of parenteral treatments, the injectable drug delivery technology market is likely to rise significantly in the coming years.

Injectable Drug Delivery Devices Market Prominent Players
Major players in the injectable drug delivery devices market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi.

Request A Sample Of The Global Injectable Drug Delivery Devices Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp

The Injectable Drug Delivery Devices Global Market Report 2023  provides a comprehensive overview on the injectable drug delivery devices market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the injectable drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Injectable drug delivery devices are utilised for a variety of drug administration routes, including intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular administration.

View More Related Reports –
Drugs For Erectile Dysfunction Global Market Report 2023
Drugs For Immunotherapy Global Market Report 2023
Drug Delivery Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model